The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of...
Vous n'êtes pas connecté
GENEVA, Switzerland – The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of type 2 diabetes and obesity in some countries. The alert addresses 3 falsified batches of product of semaglutide class of medicines (of specific brand Ozempic), which have been detected in Brazil […]
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of...
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of...
June 21, 2024. Azonuchechi Chukwu. The World Health Organisation (WHO) has issued a medical product alert on falsified semaglutides, the type of...
Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.
GEORGETOWN, Guyana, CMC – Health authorities in Guyana on Wednesday warned against the use of falsified drugs to treat diabetes. The Analyst-Food...
CNN — People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say...
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...
The World Health Organization (WHO) has released a public warning over the spread of fraudulent diabetic drugs that have been available worldwide...
The WHO reports counterfeit diabetes drugs circulating globally, posing serious health risks. Recent findings reveal fake Ozempic in the UK, US and...
WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...